Achilles Therapeutics plc - Bathi resik saben saham sajrone 12 wulan pungkasan ACHL

Achilles Therapeutics (ACHL) - logo korporat

The lack of revenue and dependence on lung therapy trials create tension for Achilles Therapeutics (ACHL), yet the year-over-year change in net income per share over a rolling period illustrates the capital dynamics. The value of -14.90 determines the current status of the parameter. Biomanufacturing risks and additional share issuances are offset by the non-cyclical demand for innovation, which remains independent of GDP or inflationary shocks.

achillestx.com (ACHL): Bathi saben saham sajrone rolas wulan pungkasan saka 11.02.2024 nganti 20.02.2024

Rincian metrik keuangan lan pasar Achilles Therapeutics plc (ACHL)

- rincian nilai pasar emiten:
Pambiji fundamental perusahaan:ACHL Achilles Therapeutics PLC
Barang unggulan achillestx.com

This indicator measures the annual change in net earnings per share, identifying hidden business efficiency trends in real time. For Achilles Therapeutics (ACHL), this metric reflects the return on investment in robotic gene-editing automation. By analyzing this 12-month YoY EPS growth chart, one can assess the impact of technological precision on financial stability. The curve's dynamics allow for stress-testing the company's capitalization, which is critical for minimizing portfolio risks.